Literature DB >> 11278469

Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79.

M Cong1, S J Perry, F T Lin, I D Fraser, L A Hu, W Chen, J A Pitcher, J D Scott, R J Lefkowitz.   

Abstract

The beta2 adrenergic receptor (beta2AR) undergoes desensitization by a process involving its phosphorylation by both protein kinase A (PKA) and G protein-coupled receptor kinases (GRKs). The protein kinase A-anchoring protein AKAP79 influences beta2AR phosphorylation by complexing PKA with the receptor at the membrane. Here we show that AKAP79 also regulates the ability of GRK2 to phosphorylate agonist-occupied receptors. In human embryonic kidney 293 cells, overexpression of AKAP79 enhances agonist-induced phosphorylation of both the beta2AR and a mutant of the receptor that cannot be phosphorylated by PKA (beta2AR/PKA-). Mutants of AKAP79 that do not bind PKA or target to the beta2AR markedly inhibit phosphorylation of beta2AR/PKA-. We show that PKA directly phosphorylates GRK2 on serine 685. This modification increases Gbetagamma subunit binding to GRK2 and thus enhances the ability of the kinase to translocate to the membrane and phosphorylate the receptor. Abrogation of the phosphorylation of serine 685 on GRK2 by mutagenesis (S685A) or by expression of a dominant negative AKAP79 mutant reduces GRK2-mediated translocation to beta2AR and phosphorylation of agonist-occupied beta2AR, thus reducing subsequent receptor internalization. Agonist-stimulated PKA-mediated phosphorylation of GRK2 may represent a mechanism for enhancing receptor phosphorylation and desensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278469     DOI: 10.1074/jbc.M009130200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Genetic polymorphisms of adrenergic receptors.

Authors:  E M Garland; I Biaggioni
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 2.  AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes.

Authors:  Craig C Malbon; Jiangchuan Tao; Hsien-yu Wang
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

Review 3.  Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

4.  Near-field scanning fluorescence microscopy study of ion channel clusters in cardiac myocyte membranes.

Authors:  Anatoli Ianoul; Melissa Street; Donna Grant; John Pezacki; Rod S Taylor; Linda J Johnston
Journal:  Biophys J       Date:  2004-08-31       Impact factor: 4.033

Review 5.  Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Shyamal K Goswami; Sathyamangla V Naga Prasad
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

6.  Dual mode of glucagon receptor internalization: role of PKCα, GRKs and β-arrestins.

Authors:  Lada Krilov; Amy Nguyen; Teruo Miyazaki; Cecilia G Unson; Russell Williams; Norman H Lee; Susan Ceryak; Bernard Bouscarel
Journal:  Exp Cell Res       Date:  2011-10-06       Impact factor: 3.905

Review 7.  Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.

Authors:  Louis M Luttrell
Journal:  Mol Biotechnol       Date:  2008-02-01       Impact factor: 2.695

Review 8.  Alveolar epithelial beta2-adrenergic receptors.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-20       Impact factor: 6.914

9.  GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Authors:  Allison Doyle Brackley; Ruben Gomez; Armen N Akopian; Michael A Henry; Nathaniel A Jeske
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

10.  Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor.

Authors:  Jiangchuan Tao; Hsien-Yu Wang; Craig C Malbon
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.